MR1 BIOCHEMICAL FEATURES AND IMMUNOLOGICAL FUNCTIONS

MR1 生化特征和免疫功能

基本信息

  • 批准号:
    7984905
  • 负责人:
  • 金额:
    $ 38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-09-30 至 2015-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Elimination of pathogen-infected cells requires their sequential recognition by cells in the innate and acquired immune systems. A unique category of T cells collectively referred to as 'innate T cells' kinetically bridge the innate and acquired immune responses. Interestingly, the activation of innate T cells can be restricted by the expression of MHC-like molecules or class Ib molecules. The ability of innate T cells to respond rapidly stems from their lack of dependence on clonal expansion, resulting from less discriminating receptor-ligand interactions. By comparison, classical MHC molecules restrict conventional CD4 and CD8 T cells in the acquired immune response, and they require 10-14 days to clonally expand to sufficient numbers due to highly specific receptor-ligand interactions. The experiments in this grant will characterize the novel class Ib molecule MR1 that is evolutionarily conserved in mammals and restricts the development of mucosal-associated invariant T cells or MAIT cells in a manner dependent upon the commensal flora and B cells. MAIT cells have several features consistent with their function as innate T cells including i) invariant T cell receptor alpha chains, ii) the ability to rapidly release cytokines, and iii) apparent recognition of an evolutionarily conserved ligand. However, the nature of the MR1 ligand is unknown as is the physiological role of MAIT cells. In this application we will test whether MAIT cells detect Mycobacterium tuberculosis-infected cells and are critical components of host resistance to this pathogen. In addition, we will elucidate the nature of the MR1 ligand, the pathway by which it is presented, and the crystal structure of a ligand/MR1 complex. Cellular, molecular and structural dissection of MR1 antigen presentation to MAIT cells will critically define the mechanism and importance of this pathway in protective immunity to bacteria. PUBLIC HEALTH RELEVANCE: Mucosal immune responses provide a front line defense against infection. In this grant we will study how a unique subset of T cells associated with mucosal tissues potentially control early immunity to Mycobacterium tuberculosis. Our findings will define the mechanism of bacteria recognition by these mucosal T cells and their function in controlling disease.
描述(由申请人提供):消除病原体感染的细胞需要先天和获得性免疫系统中的细胞对其进行顺序识别。一种被统称为“先天T细胞”的独特类型的T细胞可以动态地桥接先天和获得性免疫反应。有趣的是,先天T细胞的激活可以受到mhc样分子或Ib类分子表达的限制。先天T细胞快速反应的能力源于它们缺乏对克隆扩增的依赖,这是由较少的鉴别受体-配体相互作用造成的。相比之下,传统的MHC分子在获得性免疫反应中限制了传统的CD4和CD8 T细胞,由于高度特异性的受体-配体相互作用,它们需要10-14天才能克隆扩增到足够的数量。本次资助的实验将表征新型Ib类分子MR1,该分子在哺乳动物中具有进化保守性,并以依赖于共生菌群和B细胞的方式限制粘膜相关不变T细胞或MAIT细胞的发育。MAIT细胞具有与先天T细胞功能一致的几个特征,包括i)不变的T细胞受体α链,ii)快速释放细胞因子的能力,以及iii)明显识别进化上保守的配体。然而,MR1配体的性质和MAIT细胞的生理作用都是未知的。在这个应用程序中,我们将测试MAIT细胞是否检测结核分枝杆菌感染的细胞,并且是宿主抵抗这种病原体的关键组成部分。此外,我们将阐明MR1配体的性质,其呈现的途径,以及配体/MR1复合物的晶体结构。MR1抗原呈递到MAIT细胞的细胞、分子和结构解剖将关键地确定该途径在细菌保护性免疫中的机制和重要性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TED Howard HANSEN其他文献

TED Howard HANSEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TED Howard HANSEN', 18)}}的其他基金

MR1 BIOCHEMICAL FEATURES AND IMMUNOLOGICAL FUNCTIONS
MR1 生化特征和免疫功能
  • 批准号:
    8168705
  • 财政年份:
    2010
  • 资助金额:
    $ 38万
  • 项目类别:
MR1 BIOCHEMICAL FEATURES AND IMMUNOLOGICAL FUNCTIONS
MR1 生化特征和免疫功能
  • 批准号:
    7953920
  • 财政年份:
    2009
  • 资助金额:
    $ 38万
  • 项目类别:
MR1 BIOCHEMICAL FEATURES AND IMMUNOLOGICAL FUNCTIONS
MR1 生化特征和免疫功能
  • 批准号:
    7721485
  • 财政年份:
    2008
  • 资助金额:
    $ 38万
  • 项目类别:
Development of a Novel WNV Vaccine that Elicits Protective T Cell Immunity
开发可引发保护性 T 细胞免疫的新型 WNV 疫苗
  • 批准号:
    7641917
  • 财政年份:
    2008
  • 资助金额:
    $ 38万
  • 项目类别:
MR1 BIOCHEMICAL FEATURES AND IMMUNOLOGICAL FUNCTIONS
MR1 生化特征和免疫功能
  • 批准号:
    7355312
  • 财政年份:
    2006
  • 资助金额:
    $ 38万
  • 项目类别:
SCT PROBES FOR PATHOGEN IMMUNITY
用于病原体免疫的 SCT 探针
  • 批准号:
    8213490
  • 财政年份:
    2004
  • 资助金额:
    $ 38万
  • 项目类别:
Applications of single chain MHC-1 molecules
单链MHC-1分子的应用
  • 批准号:
    7188010
  • 财政年份:
    2004
  • 资助金额:
    $ 38万
  • 项目类别:
SCT PROBES FOR PATHOGEN IMMUNITY
用于病原体免疫的 SCT 探针
  • 批准号:
    7886430
  • 财政年份:
    2004
  • 资助金额:
    $ 38万
  • 项目类别:
SCT PROBES FOR PATHOGEN IMMUNITY
用于病原体免疫的 SCT 探针
  • 批准号:
    8015194
  • 财政年份:
    2004
  • 资助金额:
    $ 38万
  • 项目类别:
Applications of single chain MHC-1 molecules
单链MHC-1分子的应用
  • 批准号:
    7019987
  • 财政年份:
    2004
  • 资助金额:
    $ 38万
  • 项目类别:

相似海外基金

Characterizing RNA regulation in B lymphocytes
B 淋巴细胞中 RNA 调控的特征
  • 批准号:
    502601
  • 财政年份:
    2024
  • 资助金额:
    $ 38万
  • 项目类别:
Characterization of Streptococcus suis interactions with B lymphocytes
猪链球菌与 B 淋巴细胞相互作用的表征
  • 批准号:
    573206-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 38万
  • 项目类别:
    University Undergraduate Student Research Awards
B Lymphocytes in Autoimmune Disease
自身免疫性疾病中的 B 淋巴细胞
  • 批准号:
    10370125
  • 财政年份:
    2022
  • 资助金额:
    $ 38万
  • 项目类别:
Altered B lymphocytes Due to Tungstate Exposure
钨酸盐暴露导致 B 淋巴细胞发生改变
  • 批准号:
    RGPIN-2020-05899
  • 财政年份:
    2022
  • 资助金额:
    $ 38万
  • 项目类别:
    Discovery Grants Program - Individual
The regulation of signaling and cytoskeletal rearrangements in B-lymphocytes
B 淋巴细胞信号传导和细胞骨架重排的调节
  • 批准号:
    RGPIN-2019-04911
  • 财政年份:
    2022
  • 资助金额:
    $ 38万
  • 项目类别:
    Discovery Grants Program - Individual
Myocardial-associated B lymphocytes and inflammatory injury
心肌相关B淋巴细胞与炎症损伤
  • 批准号:
    10543825
  • 财政年份:
    2022
  • 资助金额:
    $ 38万
  • 项目类别:
Myocardial-associated B lymphocytes and inflammatory injury
心肌相关B淋巴细胞与炎症损伤
  • 批准号:
    10339541
  • 财政年份:
    2022
  • 资助金额:
    $ 38万
  • 项目类别:
Exploring RNA helicase DDX the role of the1 at the crossroad of DNA repair processes in B lymphocytes
探索 RNA 解旋酶 DDX 在 B 淋巴细胞 DNA 修复过程十字路口的作用
  • 批准号:
    BB/X511560/1
  • 财政年份:
    2022
  • 资助金额:
    $ 38万
  • 项目类别:
    Training Grant
Role and regulation of extracellular vesicles generated in response to stimulation of CD24 on B lymphocytes
B 淋巴细胞上 CD24 刺激产生的细胞外囊泡的作用和调节
  • 批准号:
    RGPIN-2022-03800
  • 财政年份:
    2022
  • 资助金额:
    $ 38万
  • 项目类别:
    Discovery Grants Program - Individual
B Lymphocytes in Autoimmune Disease
自身免疫性疾病中的 B 淋巴细胞
  • 批准号:
    10640819
  • 财政年份:
    2022
  • 资助金额:
    $ 38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了